MIAMI, Dec. 17, 2020 (World NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of electronic therapeutics delivering proof-based therapeutic interventions to clients, announces that Ben Kaplan, President, Main Government Officer and Chairman, has issued a letter to Ehave’s stockholders. The complete textual content is as follows:
To My Fellow Stockholders,
More than the course of 2020, Ehave, Inc. has produced significant development in advancing our strategic program and hit several milestones in our journey. From a corporate standpoint, we are a totally reporting company with the SEC. We have utilized for OTCQB registration and anticipate filing with the Canadian Securities Trade by the stop of the 12 months. The put together initiatives of our management staff, Board of Administrators, and health-related advisory board has resulted in a lot of achievements together with the following highlights:
Ehave expanded its psychedelic mental overall health platform to much better serve scientists and clinicians, even though also permitting clients to choose more handle about their psychedelic professional medical documents. The Ehave Dashboard is a info driven platform that has been strategically produced to supply much better communication among clinical practitioners and wellness treatment suppliers. The aggregation of data and facts into just one software has proven successful in streamlining the well being system for the two clients and companies. The cloud based mostly system can supply crucial capabilities and abilities to healthcare companies, all although enabling seamless integrations with every thing from digital well being documents (EHRs) to telehealth companies to psychedelic researchers and clinicians. The Ehave Dashboard has been created by means of decades of tests with psychological healthcare gurus at a single of Canada’s major hospitals. In addition to supplying improved results, the proprietary platform allows persons to get management of their actual physical and mental health. 2020 marked a to start with for our Business as our facts system permitted sufferers to access innovative remedies to mental wellness by offering clinicians and pharmaceutical providers with details that will make the provision of treatment a lot more quickly out there.
Ehave will utilize its Dashboard and digital technologies to support psychedelic drugs providers in the generation of the new paradigm in how mental well being is handled. Ehave concentrate on patients, physicians, and scientists to assist them swiftly authenticate or launch particular, verified info and give more management in circumstances exactly where belief are not able to be compromised. By using blockchain engineering, Ehave can offer you its clinical associates an option to decreased their administration costs by up to 90%.
Our most important concentration is, and often has been, improving psychological wellbeing and combatting mental sickness. Approximately 1 in five (19 %) U.S. grownups encounter some sort of psychological health issues and just one adult in 24 (4.1 p.c) has a major psychological disease. Mental health issues is treatable and our mission is to address even those with severe psychological health issues. Throughout the U.S. economy, critical mental sickness triggers $193.2 billion in dropped earnings each and every yr, though despair and stress ailments value the world economy $1 trillion in shed efficiency each 12 months. Suicide is the 10th leading induce of loss of life in the U.S. and 90% of people today who died by suicide experienced demonstrated symptoms of a mental overall health condition, according to interviews with loved ones, pals and medical experts. When you make strides in assisting individuals with mental health, you get recognized. We have been constantly finding protection all-around the technology and partnerships we are developing.
Mycotopia Therapy. Mycotopia Remedy is a wholly-owned subsidiary of Ehave that provides a new paradigm for psychological wellness. Our major goal by way of Mycotopia Therapy is to present a human knowledge of setting up a roadmap of exceptional brain-entire body-spirit well being. Our medical professionals and practitioners are disrupting the landscape by offering certainty on what is occurring and what to do about it. Mycotopia Therapy has remodeled into an ecosystem to nurture the development of therapies making use of psychedelics. Ehave, as a result of its Mycotopia Therapy subsidiary, owns 10% of the firm that provides the PsyTech Psychedelic Marketplace Virtual investor Conferences and lately announced designs to offer you psychedelic retreats. The psilocybin-guided wellness retreats will be supplied in different locations around the entire world, and will be supervised by competent medical professionals in a safe and sound, legal, and snug location. These retreats will be in conjunction with our partner centers.
In January, 2020 Ehave announced the buy of a 10 % stake in Psychedelitech, Inc. by way of the Mycotopia Therapy subsidiary. Psychedelitech is the guardian firm of PsyTech, the world’s most regarded psychedelic convention. As a consequence of a modern monetary transaction, Psychedelitech is valued at $15 million, earning Ehave’s financial investment really worth $1.5 million. Speakers at the PsyTech Virtual Investor Conferences have included Dude Lieberman, Director of Nahana Foundation Liana Gillooly, Founder/Advancement Officer at North Star/MAPS David Nikzad, Founder of Orthogonal Thinker Inc./Ei.Ventures Stacey Wallin, Co-Founder and Main Technique Officer at Numinus Wellness, Inc. Rick Doblin, Ph.D., Founder and Government Director of the Multidisciplinary Association for Psychedelic Research (MAPS) Todd Shapiro of Red Mild Holland Matthew Johnson, PhD., Professor of Psychiatry and Conduct at Johns Hopkins Christian Angermayer, Founder of ATAI Existence Sciences Dr. Rosalid Watts, Scientific Psychologist at the Psychedelic Investigate Group at Imperial Faculty London Bruce Linton, Founder, and Former Chairman and Co-CEO of Cover Advancement Company and Dr. Mark Braunstein, The Hashish Psychiatrist and PsyTech Healthcare Advisor.
Partnership with Identification Essential. Ehave recently announced it would be offering blockchain based mostly identity verification application for the healthcare group as a plug-in on its Dashboard. Adopting blockchain technologies to Ehave’s Dashboard has the likely to renovate wellness care, putting the patient at the center of the health and fitness treatment ecosystem and growing the safety, privateness, and interoperability of well being info. Blockchain know-how is building substantial opportunities for individuals, health professionals, and scientists to access details in new methods with audit trails and verifiable authentication. On the web ID verification is observing a spike in demand from customers driven by the existing pandemic as quite a few clinical specialists send their staff members to function remotely. For the duration of the pandemic there has been a solid surge in demand from customers for videoconferencing communication in between patients, vendors, professionals, and other healthcare experts. Medical records and client information are continue to needed by law to be protected. Client identification and verification is 1 of the most challenging difficulties the healthcare sector faces all through these turbulent moments, but it is critical in imparting quick and efficient health care companies to people. Ehave can give a protected blockchain alternative to psychedelic clinicians and researchers, as properly as other health-related industry experts.
With a renewed research curiosity in LSD, MDMA, Ketamine, and Psilocybin, and a expanding normalization immediately after decades of stigma, psychedelics are swiftly starting to be the upcoming therapeutic frontier. Ehave lately announced the formation of KetaDASH an Intravenous (IV) based mostly, dwelling supply system for clients who have been recommended Ketamine. Ehave procured the tangible and intangible assets of CureDash, which now operates an IV delivery system that will become the backbone of KetaDash. By giving the platform for health-related practitioners to administer Ketamine intravenously to patients at home, we consider a lot of extra clients will get the remedy they involve. Ketamine is currently utilized to assistance simplicity soreness and lets sedatives to be effective at decrease doses, lessening the amount of money of perhaps addictive ache medication demanded following sure healthcare treatments. Ketamine is now remaining examined as a treatment method for significant despair, though it has not nonetheless been authorized by the Fda to deal with depression. The KetaDASH platform will consist of software, staffing, protocols, and equipment. Ehave has made a clever and intuitive dashboard for KetaDash from the place the purchasers and the associated nurses can get comprehensive insight on how the Ketamine therapy is working. Sufferers will be capable to build a profile, check out availability of administering nurses, and agenda appointments. Individuals are paying a lot more time at household and residence shipping and delivery has turn out to be extra common.
Ketamine was at first approved by the US Food and Drug Administration (Fda) in 1970 as an anesthetic agent that was administered intravenously or intramuscularly for use in diagnostic and surgical techniques. It is now readily available generically. Ketamine is now becoming studied as a therapy for significant depression, while it has not still been accredited by the Fda to address depression. Esketamine (Spravato, Janssen) was accredited by the Fda previous calendar year for remedy-resistant melancholy. Esketamine is a treatment applied as a normal anesthetic and for remedy-resistant despair. Esketamine is used as a nasal spray or by injection into a vein. Esketamine functions mostly as a non-competitive N-methyl-D-aspartate receptor antagonist. Numerous health-related industry experts think Ketamine may have a exclusive prospective particularly for most cancers-relevant depression.
Addition of Important Personnel. Even though Ehave has a reasonably flat organizational construction, we constantly have a want for powerful administration and a very well-qualified Board. 2020 marked the addition of many people joining the Organization.
Alfred Farrington II joined our enterprise as the Main Details Officer. Mr. Harrington’s main target is investigation and development of substantial-overall performance technologies devices and systems for collecting, examining, and processing efficiency knowledge to deliver productive remedies to age-outdated problems.
Dr. Nithin Krishna, M.D., a neuroscience researcher, joined Ehave’s Health care Advisory Board. As a member of the Company’s Healthcare Advisory Board, Dr. Krishna’s major duties will be to assist and suggest the Business on human trials for its cognitive and psychedelic alternatives.
Victor S. Dorodny, MD, PhD, MPH joined our Advisory Board and will advise Ehave on HIPAA compliance and telemedicine engineering. Dr. Dorodny was one of the creators of the Well being Insurance policy Portability and Accountability Act of 1996 (HIPAA). He has served on the Advisory Board of the Affiliation of Professional medical Director of Data Techniques and is the Past President of the Western Division of the Nationwide Affiliation of Managed Treatment Doctors. Dr. Dorodny has served in an government ability of several corporations in which he has held the title of Main Medical Data Officer, Chief Scientific Advisor, and Chief Clinical Officer.
Russell Schachar, MD, FRCP(C) joined Ehave as Main Clinical Officer. Dr. Schachar is a training boy or girl and adolescent psychiatrist, Professor in the Office of Psychiatry at the College of Toronto, and Senior Scientist in the Analysis Institute at the Clinic for Sick Kids in Toronto, Canada where by he holds the TD Financial institution Chair in Little one and Adolescent Psychiatry and heads a cognitive neurosciences laboratory which focuses on psychiatric ailments of childhood and adolescence.
Dr. Manideep Reddy (MD,MBA) is a solution concentrated physician and health care marketing consultant professional in doing the job with consumer, federal government and business experiencing projects. His modern engagements involve setting up a Molecular genetics challenge, telemedicine infrastructure for medical center chain in Singapore and Malaysian current market, compliance and distribution infrastructure for neuroscience remedies, molecular commercialization exit pathways for its generic molecules in cardiopulmonary and rheumatological conditions, and the deal producing amenities across 5 spots in India to manufacture the generic molecules for immunological and dermatological diseases.
As I talked about, we are delighted with our development to date and are very enthusiastic about our momentum and Ehave’s long term potential customers. I would like to thank our employees, associates, and Advisory Board for their outstanding initiatives and commitment, and our traders for their continued assist. We glance forward to a solid 2021.
Additional Ehave Inc. Data
We are genuinely grateful for the guidance of EHVVF shareholders! Please be part of the discussion on our Ehave supporter’s telegram team at https://t.me/EhaveInc.
The enterprise diligently posts crucial info and updates by weekly videos from the official corporation YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA.
Remember to abide by Ehave on Twitter @Ehaveinc1
About Ehave, Inc.
Ehave, Inc. (EHVVF) is a leader of electronic therapeutics delivering proof-centered therapeutic interventions to patients. Our primary aim is on strengthening the regular treatment in therapeutics to avoid or handle brain diseases or conditions through the use of digital therapeutics, independently or with each other, with drugs, gadgets, and other therapies to enhance client treatment and health outcomes. Our principal product or service is the Ehave Telemetry Portal, which is a psychological well being informatics platform that will allow clinicians to make goal and smart selections via info insights. The Ehave Infinity Portal features a impressive device mastering and artificial intelligence system with a growing established of innovative applications and purposes created by Ehave and its major associates. This empowers people, healthcare suppliers, and payers to address a huge range of disorders by means of substantial high quality, risk-free, and efficient info-driven involvement with clever and available instruments. For extra data go to: www.ehave.com.
Forward-Seeking Statement Disclaimer
This press launch contains “forward-looking statements” within just the indicating of the Private Securities Litigation Reform Act of 1995. This kind of statements may well be preceded by the text “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or identical words. Forward-wanting statements are dependent on sure assumptions and are issue to several recognized and mysterious challenges and uncertainties, many of which are outside of the Company’s command, and are not able to be predicted or quantified and for that reason, precise results could vary materially from these expressed or implied by such forward-wanting statements: (i) the initiation, timing, progress and benefits of the Company’s analysis, production and other growth endeavours (ii) the Company’s capability to advance its solutions to efficiently complete progress and commercialization (iii) the manufacturing, advancement, commercialization, and market acceptance of the Company’s solutions (iv) the absence of sufficient funding to finance the solution enhancement and organization functions (v) aggressive organizations and technologies inside of the Company’s marketplace and introduction of competing products (vi) the Company’s capability to set up and manage company collaborations (vii) decline of vital management staff (viii) the scope of safety the Corporation is in a position to create and manage for intellectual house legal rights covering its products and its potential to run its business enterprise without having infringing the mental assets legal rights of others (ix) likely failure to comply with relevant well being information and facts privateness and protection guidelines and other state and federal privacy and security laws and (x) the problems of predicting steps of the United states Fda and its polices. All ahead-hunting statements provided in this press release are produced only as of the day of this press release. The Corporation assumes no obligation to update any created or oral forward-looking assertion unless essential by law. Additional thorough data about the Organization and the chance variables that might influence the realization of ahead-wanting statements is contained under the heading “Hazard Components” in Ehave, Inc.’s Registration Assertion on Type F-1 filed with the Securities and Exchange Fee (SEC) on September 24, 2015, as amended, which is readily available on the SEC’s web-site, https://www.sec.gov.
For Trader Relations, you should get in touch with:
Telephone: (623) 261-9046
Email: [email protected]